Research Output per year
Fingerprint Dive into the research topics where Laura Ferrari is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Breast Neoplasms
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Doxorubicin
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Colorectal Neoplasms
Medicine & Life Sciences
exemestane
Medicine & Life Sciences
oxaliplatin
Medicine & Life Sciences
Cyclophosphamide
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1982 2019
Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study
Mariani, G., Galli, G., Cavalieri, S., Valagussa, P., Bianchi, G. V., Capri, G., Cresta, S., Ferrari, L., Damian, S., Duca, M., de Braud, F. & Moliterni, A., Mar 1 2019, In : Breast Journal. 25, 2, p. 237-242 6 p.Research output: Contribution to journal › Article
Anthracyclines
Breast Neoplasms
Drug Therapy
Paclitaxel
Methotrexate
Bone metastases in biliary cancers: A multicenter retrospective survey
Santini, D., Brandi, G., Aprile, G., Russano, M., Cereda, S., Leone, F., Lonardi, S., Fornaro, L., Scartozzi, M., Silvestris, N., Barni, S., Pantano, F., Vincenzi, B., Palloni, A., Frega, G., Casagrande, M., Ferrari, L., Dadduzio, V., Intini, R., Filippi, R. & 7 others, , Sep 2018, In : Journal of Bone Oncology. 12, p. 33-37 5 p.Research output: Contribution to journal › Article
Biliary Tract Neoplasms
Bone Neoplasms
Diphosphonates
Neoplasm Metastasis
Bone and Bones
Erratum to: Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy (The Oncologist, (2017), 22, 12, (1463-1469), 10.1634/theoncologist.2017-0158)
Fanotto, V., Uccello, M., Pecora, I., Rimassa, L., Leone, F., Rosati, G., Santini, D., Giampieri, R., Di Donato, S., Tomasello, G., Silvestris, N., Pietrantonio, F., Battaglin, F., Avallone, A., Scartozzi, M., Lutrino, E. S., Melisi, D., Antonuzzo, L., Pellegrino, A., Ferrari, L. & 8 others, , Feb 1 2018, In : Oncologist. 23, 2, 1 p.Research output: Contribution to journal › Comment/debate
Medical Oncology
Italy
Stomach Neoplasms
Publications
Drug Therapy
1
Citation
(Scopus)
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience
Pizzuti, L., Giordano, A., Michelotti, A., Mazzotta, M., Natoli, C., Gamucci, T., De Angelis, C., Landucci, E., Diodati, L., Iezzi, L., Mentuccia, L., Fabbri, A., Barba, M., Sanguineti, G., Marchetti, P., Tomao, S., Mariani, L., Paris, I., Lorusso, V., Vallarelli, S. & 30 others, , Jan 1 2018, (Accepted/In press) In : Journal of Cellular Physiology.Research output: Contribution to journal › Article
exemestane
Confidence Intervals
Breast Neoplasms
Toxicity
Therapeutics
8
Citations
(Scopus)
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients
Cazzaniga, M. E., Airoldi, M., Arcangeli, V., Artale, S., Atzori, F., Ballerio, A., Bianchi, G. V., Blasi, L., Campidoglio, S., Ciccarese, M., Cursano, M. C., Piezzo, M., Fabi, A., Ferrari, L., Ferzi, A., Ficorella, C., Frassoldati, A., Fumagalli, A., Garrone, O., Gebbia, V. & 20 others, , Oct 2017, In : Breast. 35, p. 115-121 7 p.Research output: Contribution to journal › Article
exemestane
Epidermal Growth Factor
Hormones
Breast Neoplasms
Safety